טוען...
Oxytocin and cardioprotection in diabetes and obesity
Oxytocin (OT) emerges as a drug for the treatment of diabetes and obesity. The entire OT system is synthesized in the rat and human heart. The direct myocardial infusion with OT into an ischemic or failing heart has the potential to elicit a variety of cardioprotective effects. OT treatment attenuat...
שמור ב:
| הוצא לאור ב: | BMC Endocr Disord |
|---|---|
| Main Authors: | , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
BioMed Central
2016
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4895973/ https://ncbi.nlm.nih.gov/pubmed/27268060 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12902-016-0110-1 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|